XTLB
XTLB clinical trials: XTL BIOPHARMACEUTICALS LTD
Every trial on ClinicalTrials.gov where XTL BIOPHARMACEUTICALS LTD is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 3
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
XTLB on the catalyst calendar · XTLB registry changes
- Primary completion Dec 2008ActualPhase 2NCT00597649A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral NeuropathyXTL Biopharmaceuticals · Chronic Peripheral Neuropathy Pain in DiabeticsTerminatedXTLBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 2NCT00553592Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With DiabetesXTL Biopharmaceuticals · Diabetic Peripheral NeuropathyUnknown statusXTLBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 1NCT00300807Study of XTL6865 in Patients With Chronic Hepatitis C Virus InfectionXTL Biopharmaceuticals · Hepatitis CUnknown statusXTLBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 1NCT00255359Safety, Tolerability and Efficacy of XTL 2125 in HCV-Infected Patients Who Are Interferon-Alpha Non-Responders or RelapsersHadassah Medical Organization · Chronic Hepatitis C Virus InfectionWithdrawnXTLBCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner